Anti-inflammatory Effects of Simvastatin on Human Oral Cells

  • Sakoda Kenji
    Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences
  • Yamamoto Matsuo
    Department of Periodontology, School of Dentistry, Showa University
  • Negishi Yoichi
    School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Liao James K
    Vascular Medicine Unit, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, U.S.A.
  • Node Koichi
    Department of Cardiovascular & Renal Medicine, Saga University Faculty of Medicine
  • Izumi Yuichi
    Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences

この論文をさがす

抄録

Periodontitis is a chronic inflammatory disease associated with degradation of periodontal tissues and is highly prevalent in late middle age.<BR>Statins, such as simvastatin, are pharmacologic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors that inhibit cholesterol synthesis, which is important in development of arteriosclerosis. Many cardiovascular studies have suggested that statins also have anti-inflammatory effects which are independent of cholesterol lowering. As a chronic inflammatory disease, periodontitis shares some mechanisms with atherosclerosis. Since oral epithelial cells are implicated in periodontal inflammation, we measured simvastatin effects on cytokine [interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12p70, and tumor necrosis factor α (TNFα)] production by cultured human epithelioid cell line KB cells in response to IL-1α. Simvastatin decreased production, an effect reversed by adding mevalonate or geranylgeranyl pyrophosphate (GGPP), but not farnesyl pyrophosphate (FPP). Simvastatin was found to reduce NF-κB and AP-1 promoter activity in KB cells. Our results support an anti-inflammatory effect of simvastatin on human oral epithelial cells.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ